The burgeoning field of weight management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These novel therapies represent a significant https://jakubqcww970955.aioblogs.com/91402550/glp-3-receptor-agonists-retatrutide-trizepatide